Literature DB >> 3733855

Pattern of toxicity by titanocene dichloride in mice. Blood and urine chemical parameters.

P Köpf-Maier, S Gerlach.   

Abstract

The pattern of organ toxicity after single injections of the antitumor agent titanocene dichloride (TDC) in ED90 (40 mg/kg) and LD10 (60 mg/kg) doses to female mice was investigated by analyzing various blood chemical parameters and the composition of urine at intervals between 30 min and 16 days after administration. Whereas the serum levels of electrolytes, blood urea nitrogen, creatinine, total bilirubin and cholesterol did not alter, marked and simultaneous increases in serum concentrations of the enzymes GLDH, GOT and GPT occurred pointing to cellular damage within liver parenchyma; these lesions were apparently reversible within 8 and 16 days after application of TDC even at the LD10 dose. Moreover, glucose concentration decreased immediately after TDC administration, obviously stimulating a regulative output of glucagon and cortisol; these effects were also reversible within 4 to 8 days after TDC administration. No hints to nephrotoxicity induced by TDC became manifest in the present study.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3733855     DOI: 10.1007/bf00389240

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  13 in total

1.  The nephrotoxic effects of cis-diammine-dichloroplatinum (II) (NSC-119875) in male F344 rats.

Authors:  J M Ward; K A Fauvie
Journal:  Toxicol Appl Pharmacol       Date:  1976-12       Impact factor: 4.219

2.  cis-Dichlorodiammineplatinum(II) (NSC-119 875): preclinical toxicologic evaluation of intravenous injection in dogs, monkeys and mice.

Authors:  U Schaeppi; I A Heyman; R W Fleischman; H Rosenkrantz; V Ilievski; R Phelan; D A Cooney; R D Davis
Journal:  Toxicol Appl Pharmacol       Date:  1973-06       Impact factor: 4.219

3.  Acute toxicologic and pathologic effects of cis-diamminedichloroplatinum (NSC-119875) in the male rat.

Authors:  R J Kociba; S D Sleight
Journal:  Cancer Chemother Rep       Date:  1971-02

4.  Platinum compounds: a new class of potent antitumour agents.

Authors:  B Rosenberg; L VanCamp; J E Trosko; V H Mansour
Journal:  Nature       Date:  1969-04-26       Impact factor: 49.962

5.  Glucocorticoid induction of cleft palate after treatment with titanocene dichloride?

Authors:  P Köpf-Maier
Journal:  Toxicology       Date:  1985-10       Impact factor: 4.221

6.  Tumor inhibition by metallocenes: activity against leukemias and detection of the systemic effect.

Authors:  P Köpf-Maier; W Wagner; B Hesse; H Köpf
Journal:  Eur J Cancer       Date:  1981-06       Impact factor: 9.162

7.  [Tumor inhibition by metallocenes: effect of titanocene, zirconocene, and hafnocene dichlorides on Ehrlich ascites tumor in mice (author's transl)].

Authors:  P Köpf-Maier; B Hesse; H Köpf
Journal:  J Cancer Res Clin Oncol       Date:  1980-01       Impact factor: 4.553

8.  Teratogenicity and embryotoxicity of titanocene dichloride in mice.

Authors:  P Köpf-Maier; P Erkenswick
Journal:  Toxicology       Date:  1984-11       Impact factor: 4.221

9.  Antitumor metallocenes: new developments and toxicologic features.

Authors:  P Köpf-Maier; H Köpf
Journal:  Anticancer Res       Date:  1986 Mar-Apr       Impact factor: 2.480

10.  Acute nephrotoxicity following cis-dichlorodiammine-platinum.

Authors:  J D Bitran; R K Desser; A A Billings; M F Kozloff; C M Shapiro
Journal:  Cancer       Date:  1982-05-01       Impact factor: 6.860

View more
  3 in total

Review 1.  [Cytostatic non-platinum metal complexes: new perspectives for the treatment of cancer?].

Authors:  P Köpf-Maier
Journal:  Naturwissenschaften       Date:  1987-08

Review 2.  Complexes of metals other than platinum as antitumour agents.

Authors:  P Köpf-Maier
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

3.  The addition of a pregnenolone pendant group enhances the anticancer properties of titanocene dichloride in a mcf-7 xenograft model.

Authors:  Gladiany Ramos; Yaliz Loperena; Giovanni Ortiz; Fiorella Reyes; Ada Szeto; Jose Vera; Javier Velez; Jessica Morales; Deborah Morrero; Linnette Castillo; Surangani Dharmawardhane; Enrique Melendez; A Valance Washington
Journal:  Anticancer Res       Date:  2014-04       Impact factor: 2.480

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.